Pineapple gel approved for burns


A topical gel based on pineapple enzymes has been approved in the EU for use in the treatment of burns.

NexoBrid gel from privately owned biotech MediWound, contains proteolytic enzymes from the stem of the pineapple plant. It is the first pharmacological treatment for the removal of scab tissue associated with severe burns, which are typically removed surgically. Removal of scab tissue is essential to speed the healing process and prevent infection.

NexoBrid gel was designated an orphan medicine in 2002. Israeli generics giants Teva paid $163 million to raise its stake in Mediwound from 14% to 51% in 2010, according to Reuters.


Related Content

Alexion to buy Synageva for rare disease drugs

12 May 2015 Business

news image

$8.4bn deal gives firm access to enzyme drug currently under review with US and EU regulators

Traits not technology should govern EU GM laws, MPs say

27 February 2015 News and Analysis

news image

UK science and technology committee says European rules are flawed and need changing

Most Read

Agatha Christie, the queen of crime chemistry

28 August 2015 Feature

news image

Kathryn Harkup looks at how Agatha Christie used her chemical training in her detective novels

Simple chemistry saving thousands of gold miners from mercury poisoning

25 August 2015 News and Analysis

news image

Basic apparatus is cutting mercury pollution and helping Indonesian miners go for gold

Most Commented

A risky business

28 August 2015 In the Pipeline

news image

Graduate research is likely the most risky time of a chemist’s career, says Derek Lowe

Exploiting the data mine

13 August 2015 Feature

news image

Chemists must embrace open data to allow us to collectively get the best out of the masses of new knowledge we unearth, repor...